Report Categories
View AllRecent Articles
View All
GENB Generate Biomedicines leadership flags accelerated AI drug pipeline advancement as top priority in latest quarterly earnings update
CBRE Group Q1 2026 earnings crush estimates with 398 EPS beat revenue rises 134 to 4055B
CTSO Cytosorbents shares climb 6 percent today despite reporting a wider than expected Q4 2025 per share loss
What The Joint JYNT management is not saying enough about Grinds Higher 20260506